Candriam S.C.A. Haemonetics Corp Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$71.24 - $85.35 $378,711 - $453,720	5,316 New	5,316 $453,000
Q1 2023 May 12, 2023	BUY	$72.75 - $90.6 $445,448 - $554,743	6,123 New	6,123 $506,000
Q3 2018 Nov 07, 2018	SELL	$89.96 - $114.58 $449,799 - $572,900	-5,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $357,650 - $478,750	5,000 New	5,000 $448,000

348

55.7M

600K

474K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.28B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.